Join Dr. Holt and Dr. Weimer Monday at 12 PM EST for a discussion on utilizing MAUD in individuals with liver disease! Earn CE credit and learn more about this valuable treatment option for patients. #casediscussion #continuingeducation #liverdisease #alcohol pic.x.com/bfbv16b1zy

Massive series from ClinicalLiverDisease featuring great content featuring Juan Pablo (JP) Arab, MD  Luis Antonio Díaz, MD Ruben Hernaez Lorenzo Leggio Dr. Melissa Weimer jeanette tetrault edited by Jessica Mellinger Lamia Haque

A new study published in JAMA Network Open by Gail D'Onofrio et al suggests that 7-day extended-release buprenorphine is feasible in patients with OUD presenting with minimal to mild COWS scores (4-7), and may lower barriers to treatment. Read more:

Thanks to all who joined us earlier this week for grand rounds with Dr. Adam Bisaga! See you again, 7/23 12-1pm, when our very own Dr. Melissa Weimer will be speaking on medications for AUD. 🔗yalesurvey.ca1.qualtrics.com/jfe/form/SV_cH…

Thrilled to see 100+ tune into Rounds today w/ Dr. Melissa Weimer. Learn more about resources & trainings offered by PCSS-MAUD @ pcss-maud.org. We're taking our annual hiatus from Rounds in August - see you again in September for the 8th annual Schottenfeld Lecture!

July is #BIPOCMentalHealthMonth! BIPOC populations face disproportionate levels of co-occurring mental health and substance use disorders, as well as unique barriers to both mental health and substance use treatment. #bipocmentalhealth #mentalhealth #substanceuse

Our motivational interviewing (MI) online module is now live! This 90-minute module covers MI concepts and how to use MI to interact with patients. Go to pcss-maud.org to register and earn CE credit! #continuingeducation #motivationalinterviewing #alcohol #stigma

Amazing opportunity for addiction medicine fellows!

Join us tomorrow at 12 PM ET to earn CE credit and learn how SDOH influence alcohol use, AUD, and AUD treatment for people experiencing homelessness. This webinar is presented by Andrea Jodat. Register on pcss-maud.org! #continuingeducation #alcohol #homelessness

Totally agree! Check out pcss-maud.org for freely available (& excellent) education for clinicians about MAUD (meds for #alcohol use disorder)

Buprenorphine for Opioid Use Disorder—An Essential Medical Treatment | Substance Use and Addiction Medicine | JAMA Internal Medicine | JAMA Network ⁦JAMA Internal Medicine⁩ ⁦Yale School of Medicine⁩ ⁦Yale Program in Addiction Medicine⁩ jamanetwork.com/journals/jamai…

#ISAM2024 kicks off, tomorrow, in #Istanbul! Will you be attending? Don't miss your chance to hear from Yale School of Medicine Yale School of Public Health faculty, staff, & collaborators presenting at this year's proceedings! Presentation dates, times, & locations below:

Thank you for hosting me! We had a wonderful time in Spain! Yale Program in Addiction Medicine

Thank you to everyone who joined our workshop on novel buprenorphine inductions! ISAMAddiction @isam2024 Yale Program in Addiction Medicine Yale Internal Medicine

Critical and timely reporting from The Seattle Times Hannah Furfaro. We are failing kids with opioid use disorder from coast to coast.

We are so lucky to have Erica at Yale! Yale Program in Addiction Medicine is so proud!!

New toolkits available for nurses, social workers, and peer support specialists on pcss-maud.org! Our toolkits examine the role these professions play in supporting the treatment of AUD and AWS. #alcohol #nurses #socialworkers #peersupport #nationalrecoverymonth

Announcing a new abstract deadline for Yale Conference for Alcohol Research and Education (YCARE) 2024. YCARE is now accepting abstracts in all disciplines related to alcohol by Friday, September 20, 2024. Submit an abstract or register to attend below. medicine.yale.edu/internal-medic…